Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Flynn

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Orthopedics|January 8, 2011
Managing postoperative nausea and vomiting: current controversyJamie Craig, Jeremy Flynn, Kevin Hatton
Orthopedics|June 5, 2008
Considering cardiovascular risks when using NSAIDsKena Lanham, Kelly Smith, Jeremy Flynn
Journal of Thrombosis and Thrombolysis|March 22, 2017
Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerationsJonathan Bain, Alexander H Flannery, Jeremy Flynn, et al.
Journal of Thrombosis and Thrombolysis|July 2, 2014
Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical centerJonathan Bain, Daniel Lewis, Andrew Bernard, et al.
Journal of the American College of Clinical Pharmacy : JACCP|November 9, 2023
The Role of a Pharmacy Administration and Leadership Rotation within Postgraduate Year Two Critical Care Residency TrainingKomal Pandya, Ali Wiegand, Michael Behal, et al.
Journal of Thrombosis and Thrombolysis|March 7, 2018
Factor VIIa administration in orthotopic heart transplant recipients and its impact on thromboembolic events and post-transplant outcomesRyan J Winstead, Komal Pandya, Jeremy Flynn, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Orthopedics|January 8, 2011
Managing postoperative nausea and vomiting: current controversyJamie Craig, Jeremy Flynn, Kevin Hatton
Orthopedics|June 5, 2008
Considering cardiovascular risks when using NSAIDsKena Lanham, Kelly Smith, Jeremy Flynn
Journal of Thrombosis and Thrombolysis|March 22, 2017
Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerationsJonathan Bain, Alexander H Flannery, Jeremy Flynn, et al.
Journal of Thrombosis and Thrombolysis|July 2, 2014
Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical centerJonathan Bain, Daniel Lewis, Andrew Bernard, et al.
Journal of the American College of Clinical Pharmacy : JACCP|November 9, 2023
The Role of a Pharmacy Administration and Leadership Rotation within Postgraduate Year Two Critical Care Residency TrainingKomal Pandya, Ali Wiegand, Michael Behal, et al.
Journal of Thrombosis and Thrombolysis|March 7, 2018
Factor VIIa administration in orthotopic heart transplant recipients and its impact on thromboembolic events and post-transplant outcomesRyan J Winstead, Komal Pandya, Jeremy Flynn, et al.
Pageof 1